[9] Gomez-Puerta JA, Cervera R. 2014. Diagnosis and classification of the antiphospholipid syndrome. J Autoimmun; 48-49: 20-5.

[10] Cervera R, Piette JC, Font. 2002. Antiphospholipid syndrome : clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum; 46 (4): 1019-27.

[11] Gomez-Puerta JA, Cervera R. 2014. Diagnosis and classification of the antiphospholipid syndrome. J Autoimmun; 48-49: 20-5.

[12] J. Edwin Balock 2002. Harnessing Neural-immune Circuit to Control Inflammation and Shock -  - J Exp Med. - 18; 195(6): f25–f28

[13] Claude Jacque ; Jean-Michel Thurin Stress, immunité et physiologie du système nerveux - médecine sciences, vol. 18, n° 11 – 2002 - p. 1160-1166

[14] Buske-Kirschbaum A., M. Ebrecht, S. Kern, D.H. Hellhammer -  2006. Psychoneuroendocrinology Endocrine stress responses in TH1-mediated chronic inflammatory skin disease (psoriasis vulgaris)—do they parallel stress-induced endocrine changes in TH2-mediated inflammatory dermatoses (atopic dermatitis- 31, 439–446

[15] Ilia J. Elenkov. 2008 Neurohormonal-cytokine interactions: Implications for inflammation, common human diseases and wellbeing   Neurochemistry International 52 –- 40–51